Aytu BioPharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $15.0M | $44.3M | $19.4M |
| FY2023 | $14.7M | $39.4M | $23.0M |
| FY2024 | $10.9M | $27.7M | $20.0M |
| FY2025 | $10.9M | $19.0M | $31.0M |
| FY2026 | $9.1M | $35.3M | $26.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $15.0M | $44.3M | $19.4M |
| FY2023 | $14.7M | $39.4M | $23.0M |
| FY2024 | $10.9M | $27.7M | $20.0M |
| FY2025 | $10.9M | $19.0M | $31.0M |
| FY2026 | $9.1M | $35.3M | $26.3M |